Table 2 Baseline characteristics, BMD, scintigraphy results and bone turnover markers in women with and without a recent fracture.
Anthropometry | |||
|---|---|---|---|
Women with a recent fracture (n = 8) | Women without a recent fracture (n = 14) | p | |
Age (years) | 62 (58 – 71) | 66 (60 – 73) | 0.54 |
Height (cm) | 163 (159 – 168) | 162 (157 – 167) | 0.68 |
Weight (kg) | 64 (61 – 69) | 68 (57 – 84) | 0.81 |
BMI (kg/m2) | 24.2 (22.6 – 27.5) | 26.5 (22.8 – 29.8) | 0.41 |
Bone mass | |||
Total body BMC (g) | 1976 (1929 – 2051) | 2127 (1960 – 2247) | 0.207 |
Total body BMD (g/cm2) | 0.97 (0.94 – 1.04) | 1.04 (1.00 – 1.08) | 0.041 |
Scintigraphy | |||
Total skeletal uptake (%) | 28.6 (21.3 – 31.8) | 21.6 (17.0 – 24.8) | 0.048 |
Bone formation Markers | |||
S-Bone ALP (U/L) | 27.0 (24.0 – 34.5) | 21.0 (16.0 – 25.0) | 0.034 |
S-Total OC (μg/L) | 8.2 (5.5 – 13.3) | 5.8 (4.4 – 7.3) | 0.020 |
S-OC(1–49) (μg/L) | 4.9 (3.0 – 10.0) | 2.9 (2.1 – 4.4) | 0.031 |
S-cOC (μg/L) | 10.2 (6.6 – 16.5) | 6.1 (5.3 – 7.8) | 0.017 |
Bone resorption Markers | |||
S-TRACP5b (U/L) | 3.8 (2.9 – 5.2) | 2.8 (2.4 – 3.7) | 0.076 |
S-CTX-I (ng/L) | 411 (186 – 639) | 203 (173 – 253) | 0.066 |
Urine Osteocalcin | |||
U-Total OC/crea (μg/nmol) | 30.5 (27.0 – 32.1) | 25.5 (17.4 – 29.8) | 0.13 |
U-Mid OC/crea (μg/nmol) | 1.9 (1.3 – 2.4) | 1.1 (0.9 – 1.7) | 0.12 |
U-Long OC/crea (μg/nmol) | 0.03 (0.01 – 0.08) | 0.02 (0.01 – 0.03) | 0.41 |